Benzodiazepine prescribing in children under 15 years of age receiving free medical care on the General Medical Services scheme in Ireland.

Hdl Handle:
http://hdl.handle.net/10147/559148
Title:
Benzodiazepine prescribing in children under 15 years of age receiving free medical care on the General Medical Services scheme in Ireland.
Authors:
O'Sullivan, K; Reulbach, U; Boland, F; Motterlini, N; Kelly, D; Bennett, K; Fahey, T
Citation:
Benzodiazepine prescribing in children under 15 years of age receiving free medical care on the General Medical Services scheme in Ireland. 2015, 5 (6):e007070 BMJ Open
Publisher:
BMJ Open
Journal:
BMJ open
Issue Date:
Jun-2015
URI:
http://hdl.handle.net/10147/559148
DOI:
10.1136/bmjopen-2014-007070
PubMed ID:
26059522
Abstract:
To examine the prevalence and secular trends in benzodiazepine (BZD) prescribing in the Irish paediatric population. In addition, we examine coprescribing of antiepileptic, antipsychotic, antidepressant and psychostimulants in children receiving BZD drugs and compare BZD prescribing in Ireland to that in other European countries.; Data were obtained from the Irish General Medical Services (GMS) scheme pharmacy claims database from the Health Service Executive (HSE)-Primary Care Reimbursement Services (PCRS).; Children aged 0-15 years, on the HSE-PCRS database between January 2002 and December 2011, were included.; Prescribing rates were reported over time (2002-2011) and duration (≤ or >90 days). Age (0-4, 5-11, 12-15) and gender trends were established. Rates of concomitant prescriptions for antiepileptic, antipsychotics, antidepressants and psychostimulants were reported. European prescribing data were retrieved from the literature.; Rates decreased from 2002 (8.56/1000 GMS population: 95% CI 8.20 to 8.92) to 2011 (5.33/1000 GMS population: 95% CI 5.10 to 5.55). Of those children currently receiving a BZD prescription, 6% were prescribed BZD for >90 days. Rates were higher for boys in the 0-4 and 5-11 age ranges, whereas for girls they were higher in the 12-15 age groups. A substantial proportion of children receiving BZD drugs are also prescribed antiepileptic (27%), antidepressant (11%), antipsychotic (5%) and psychostimulant (2%) medicines. Prescribing rates follow a similar pattern to that in other European countries.; While BZD prescribing trends have decreased in recent years, this study shows that a significant proportion of the GMS children population are being prescribed BZD in the long term. This study highlights the need for guidelines for BZD prescribing in children in terms of clinical indication and responsibility, coprescribing, dosage and duration of treatment.
Item Type:
Article
Language:
en
Description:
To examine the prevalence and secular trends in benzodiazepine (BZD) prescribing in the Irish paediatric population. In addition, we examine coprescribing of antiepileptic, antipsychotic, antidepressant and psychostimulants in children receiving BZD drugs and compare BZD prescribing in Ireland to that in other European countries.
Keywords:
MEDICINES; DRUGS; CHILD HEALTH; ANXIETY
ISSN:
2044-6055

Full metadata record

DC FieldValue Language
dc.contributor.authorO'Sullivan, Ken
dc.contributor.authorReulbach, Uen
dc.contributor.authorBoland, Fen
dc.contributor.authorMotterlini, Nen
dc.contributor.authorKelly, Den
dc.contributor.authorBennett, Ken
dc.contributor.authorFahey, Ten
dc.date.accessioned2015-07-07T14:35:57Zen
dc.date.available2015-07-07T14:35:57Zen
dc.date.issued2015-06en
dc.identifier.citationBenzodiazepine prescribing in children under 15 years of age receiving free medical care on the General Medical Services scheme in Ireland. 2015, 5 (6):e007070 BMJ Openen
dc.identifier.issn2044-6055en
dc.identifier.pmid26059522en
dc.identifier.doi10.1136/bmjopen-2014-007070en
dc.identifier.urihttp://hdl.handle.net/10147/559148en
dc.descriptionTo examine the prevalence and secular trends in benzodiazepine (BZD) prescribing in the Irish paediatric population. In addition, we examine coprescribing of antiepileptic, antipsychotic, antidepressant and psychostimulants in children receiving BZD drugs and compare BZD prescribing in Ireland to that in other European countries.en
dc.description.abstractTo examine the prevalence and secular trends in benzodiazepine (BZD) prescribing in the Irish paediatric population. In addition, we examine coprescribing of antiepileptic, antipsychotic, antidepressant and psychostimulants in children receiving BZD drugs and compare BZD prescribing in Ireland to that in other European countries.en
dc.description.abstractData were obtained from the Irish General Medical Services (GMS) scheme pharmacy claims database from the Health Service Executive (HSE)-Primary Care Reimbursement Services (PCRS).en
dc.description.abstractChildren aged 0-15 years, on the HSE-PCRS database between January 2002 and December 2011, were included.en
dc.description.abstractPrescribing rates were reported over time (2002-2011) and duration (≤ or >90 days). Age (0-4, 5-11, 12-15) and gender trends were established. Rates of concomitant prescriptions for antiepileptic, antipsychotics, antidepressants and psychostimulants were reported. European prescribing data were retrieved from the literature.en
dc.description.abstractRates decreased from 2002 (8.56/1000 GMS population: 95% CI 8.20 to 8.92) to 2011 (5.33/1000 GMS population: 95% CI 5.10 to 5.55). Of those children currently receiving a BZD prescription, 6% were prescribed BZD for >90 days. Rates were higher for boys in the 0-4 and 5-11 age ranges, whereas for girls they were higher in the 12-15 age groups. A substantial proportion of children receiving BZD drugs are also prescribed antiepileptic (27%), antidepressant (11%), antipsychotic (5%) and psychostimulant (2%) medicines. Prescribing rates follow a similar pattern to that in other European countries.en
dc.description.abstractWhile BZD prescribing trends have decreased in recent years, this study shows that a significant proportion of the GMS children population are being prescribed BZD in the long term. This study highlights the need for guidelines for BZD prescribing in children in terms of clinical indication and responsibility, coprescribing, dosage and duration of treatment.en
dc.language.isoenen
dc.publisherBMJ Openen
dc.rightsArchived with thanks to BMJ openen
dc.subjectMEDICINESen
dc.subjectDRUGSen
dc.subjectCHILD HEALTHen
dc.subjectANXIETYen
dc.titleBenzodiazepine prescribing in children under 15 years of age receiving free medical care on the General Medical Services scheme in Ireland.en
dc.typeArticleen
dc.identifier.journalBMJ openen

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.